Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Esserman

Showing results (251-260 of 308) with videos related to

Pageof 31
Sort By:
Radiology|June 6, 2023
Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational StudyVignesh A Arasu, Laurel A Habel, Ninah S Achacoso, et al.
NPJ Precision Oncology|May 15, 2023
Development and testing of a polygenic risk score for breast cancer aggressivenessYiwey Shieh, Jacquelyn Roger, Christina Yau, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 17, 2016
MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trialPatrick J Bolan, Eunhee Kim, Benjamin A Herman, et al.
Cancers|September 23, 2022
Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant ImmunotherapyWen Li, Nu N Le, Natsuko Onishi, et al.
Breast Cancer Research : BCR|April 11, 2026
A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapyKayla M Switalla, Natsuko Onishi, Ella F Jones, et al.
Genome Medicine|August 28, 2025
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trialKirkpatrick B Fergus, Rachel S Heise, Lisa Madlensky, et al.
Breast Cancer Research and Treatment|December 3, 2024
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancerHope S Rugo, Mike Campbell, Christina Yau, et al.
Annals of Surgical Oncology|August 7, 2014
Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstructionAmy C Degnim, Tanya L Hoskin, Rushin D Brahmbhatt, et al.
NPJ Breast Cancer|October 24, 2025
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trialAndrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissueNadine Goldhammer, Marin Bont, Shruti Warhadpande, et al.
Pageof 31

Showing results (251-260 of 308) with videos related to

Sort By:
Pageof 31
Radiology|June 6, 2023
Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational StudyVignesh A Arasu, Laurel A Habel, Ninah S Achacoso, et al.
NPJ Precision Oncology|May 15, 2023
Development and testing of a polygenic risk score for breast cancer aggressivenessYiwey Shieh, Jacquelyn Roger, Christina Yau, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 17, 2016
MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trialPatrick J Bolan, Eunhee Kim, Benjamin A Herman, et al.
Cancers|September 23, 2022
Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant ImmunotherapyWen Li, Nu N Le, Natsuko Onishi, et al.
Breast Cancer Research : BCR|April 11, 2026
A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapyKayla M Switalla, Natsuko Onishi, Ella F Jones, et al.
Genome Medicine|August 28, 2025
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trialKirkpatrick B Fergus, Rachel S Heise, Lisa Madlensky, et al.
Breast Cancer Research and Treatment|December 3, 2024
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancerHope S Rugo, Mike Campbell, Christina Yau, et al.
Annals of Surgical Oncology|August 7, 2014
Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstructionAmy C Degnim, Tanya L Hoskin, Rushin D Brahmbhatt, et al.
NPJ Breast Cancer|October 24, 2025
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trialAndrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissueNadine Goldhammer, Marin Bont, Shruti Warhadpande, et al.
Pageof 31